Tag: Ventilator

WASHINGTON – The U.S. Food and Drug Administration on June 27 highlighted updated use instructions from Philips Respironics for its BiPAP V30, BiPAP A30 and BiPAP A40 ventilators due to potential interruptions and/or loss of therapy.  Philips has updated the use instructions for the vents due to a potential failure in the ventilator inoperative alarm, which can cause therapy interruption or loss.  New instructions  If interruptions of therapy can be tolerated and...

LAFAYETTE, La. – Viemed Healthcare reported revenues of $50.6 million for the first quarter of 2024, a 28% increase over the prior year.  Net income for the quarter totaled $1.6 million; and adjusted EBITDA totaled $10.1 million, a 21% increase.  "I am tremendously enthusiastic about the company's performance, as we kick off 2024 with strong momentum," said Casey Hoyt, CEO. "Our steadfast investments in personnel and operational enhancements are yielding substantial...

SARASOTA, Fla. – React Health has secured a HCPCS code, E0468, exclusively for its V+C Ventilator with Integrated Cough Assist Technology (ICAT). The new code addresses the evolving needs of the medical community by providing a standardized and comprehensive system that combines two leading respiratory treatments into one device, the company says. The V+C delivers invasive, non-invasive and mouthpiece ventilation, as well as high-flow therapy and integrated cough to adult and pediatric patients...

YARMOUTH, Maine – A decision by Philips to exit a large chunk of the U.S. respiratory market will have a significant impact on the market, say 70% of respondents to a recent HME Newspoll.  Philips announced in January that it was discontinuing sales for 19 sleep and respiratory products, including oxygen concentrators and ventilators.  “There are very few big manufacturers left,” wrote one respondent. “Respironics had many high-quality products that will be...

AMSTERDAM – Philips Respironics has released a list of 19 sleep and respiratory products that it will stop selling in the United States as soon as this month, including the EverFlo home oxygen system and the Trilogy EVO and EV300 home ventilators.  “We have streamlined our portfolio to enable us to focus on programs that are best suited to changing market dynamics and will most effectively serve patients and customers in the future,” the company states on its website. “In...

LIVINGSTON, Tenn. – Encore Healthcare says its Nexus AI/ML Nexus engine, developed in partnership with a global artificial intelligence and machine learning research leader, can save $106 million cumulatively in health care costs over five years per 1,000 ventilator patients, representing a 46.7% reduction. In contrast, the company says traditional management systems save $25 million, a 10.8% reduction. “We leveraged cutting-edge analytics techniques and forecasted potential outcomes...

WASHINGTON – With an “absurd” denial rate as high as 86% for non-invasive ventilators for one major Medicare Advantage plan, industry stakeholders are collaborating with patient advocacy groups to elevate their concerns with CMS.  Confusion around who qualifies for NIVs vs. bi-level devices is nothing new, but recently, it’s gotten worse, says David Chandler, senior director of payer relations for AAHomecare.  “It’s escalated to what I consider...

CLEVELAND – Medical Service Company has acquired OhioHealth Home Medical Equipment in Central Ohio.  “Through its three community locations and several in-hospital offices and liaisons, OhioHealth HME supports lightning-fast discharges for the OhioHealth hospital network,” MSC stated in a press release.  MSC has also entered a long-term partnership with the OhioHealth health system, which comprises a family of 35,000 associates, physicians and volunteers, and a network...

DEERFIELD, Ill. – Baxter International has issued an urgent medical device correction for the Life2000 ventilation system due to the potential for patient oxygen desaturation (low blood oxygen) events that may occur under certain conditions when the system is connected with a third-party oxygen concentrator. Low oxygen saturation may lead to symptoms like shortness of breath, confusion, rapid heart rate or bluish skin. Among the most vulnerable patients, death, life-threatening events or permanent...

WASHINGTON – The U.S. Food and Drug Administration says efforts by Philips Respironics to notify patients and others of its recall of certain ventilators and CPAP and BiPAP devices and the risk of harm from the polyester-based polyurethan (PU-PUR) sound abatement foam used in those products have been “inadequate.”  The FDA on March 10 issued a notification order to Philips Respironics requiring the company to notify all device users, DME suppliers, distributors, retailers,...